Literature DB >> 25681871

Multimodal approaches to define network oscillations in depression.

Otis Lkuwamy Smart1, Vineet Ravi Tiruvadi2, Helen S Mayberg3.   

Abstract

The renaissance in the use of encephalography-based research methods to probe the pathophysiology of neuropsychiatric disorders is well afoot and continues to advance. Building on the platform of neuroimaging evidence on brain circuit models, magnetoencephalography, scalp electroencephalography, and even invasive electroencephalography are now being used to characterize brain network dysfunctions that underlie major depressive disorder using brain oscillation measurements and associated treatment responses. Such multiple encephalography modalities provide avenues to study pathologic network dynamics with high temporal resolution and over long time courses, opportunities to complement neuroimaging methods and findings, and new approaches to identify quantitative biomarkers that indicate critical targets for brain therapy. Such goals have been facilitated by the ongoing testing of novel invasive neuromodulation therapies, notably, deep brain stimulation, where clinically relevant treatment effects can be monitored at multiple brain sites in a time-locked causal manner. We review key brain rhythms identified in major depressive disorder as foundation for development of putative biomarkers for objectively evaluating neuromodulation success and for guiding deep brain stimulation or other target-based neuromodulation strategies for treatment-resistant depression patients.
Copyright © 2015 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Electrophysiology; Neurocircuitry; Neuroimaging; Neuromodulation; Treatment-resistant

Mesh:

Substances:

Year:  2015        PMID: 25681871      PMCID: PMC5826645          DOI: 10.1016/j.biopsych.2015.01.002

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  145 in total

Review 1.  The brainweb: phase synchronization and large-scale integration.

Authors:  F Varela; J P Lachaux; E Rodriguez; J Martinerie
Journal:  Nat Rev Neurosci       Date:  2001-04       Impact factor: 34.870

2.  Relation between frontal 3-7 Hz MEG activity and the efficacy of ECT in major depression.

Authors:  P Heikman; R Salmelin; J P Mäkelä; R Hari; H Katila; K Kuoppasalmi
Journal:  J ECT       Date:  2001-06       Impact factor: 3.635

3.  Potentiation of quantitative electroencephalograms following prefrontal repetitive transcranial magnetic stimulation in patients with major depression.

Authors:  Yoshihiro Noda; Motoaki Nakamura; Takashi Saeki; Misa Inoue; Hideo Iwanari; Kiyoto Kasai
Journal:  Neurosci Res       Date:  2013-07-01       Impact factor: 3.304

4.  Patient-specific models of deep brain stimulation: influence of field model complexity on neural activation predictions.

Authors:  Ashutosh Chaturvedi; Christopher R Butson; Scott F Lempka; Scott E Cooper; Cameron C McIntyre
Journal:  Brain Stimul       Date:  2010-04       Impact factor: 8.955

5.  Effects of repetitive transcranial magnetic stimulation in depression: a magnetoencephalographic study.

Authors:  Christian Maihöfner; Axel Ropohl; Udo Reulbach; Martin Hiller; Samuel Elstner; Johannes Kornhuber; Wolfgang Sperling
Journal:  Neuroreport       Date:  2005-11-07       Impact factor: 1.837

6.  P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder.

Authors:  A H Neuhaus; A Luborzewski; J Rentzsch; E L Brakemeier; C Opgen-Rhein; J Gallinat; M Bajbouj
Journal:  J Affect Disord       Date:  2006-11-13       Impact factor: 4.839

7.  Nuclei accumbens phase synchrony predicts decision-making reversals following negative feedback.

Authors:  Michael X Cohen; Nikolai Axmacher; Doris Lenartz; Christian E Elger; Volker Sturm; Thomas E Schlaepfer
Journal:  J Neurosci       Date:  2009-06-10       Impact factor: 6.167

8.  Default mode network mechanisms of transcranial magnetic stimulation in depression.

Authors:  Conor Liston; Ashley C Chen; Benjamin D Zebley; Andrew T Drysdale; Rebecca Gordon; Bruce Leuchter; Henning U Voss; B J Casey; Amit Etkin; Marc J Dubin
Journal:  Biol Psychiatry       Date:  2014-02-05       Impact factor: 13.382

9.  Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder.

Authors:  Jennifer S Perrin; Susanne Merz; Daniel M Bennett; James Currie; Douglas J Steele; Ian C Reid; Christian Schwarzbauer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

10.  Neuromodulation for treatment-resistant depression.

Authors:  Paul E Holtzheimer; Helen S Mayberg
Journal:  F1000 Med Rep       Date:  2012-11-01
View more
  27 in total

Review 1.  Psychiatric Illnesses as Oscillatory Connectomopathies.

Authors:  Sophia Vinogradov; Alexander Herman
Journal:  Neuropsychopharmacology       Date:  2016-01       Impact factor: 7.853

2.  Antidepressant action of HDAC inhibition in the prefrontal cortex.

Authors:  H E Covington; I Maze; V Vialou; E J Nestler
Journal:  Neuroscience       Date:  2015-04-20       Impact factor: 3.590

3.  From bed to bench side: Reverse translation to optimize neuromodulation for mood disorders.

Authors:  Peter H Rudebeck; Erin L Rich; Helen S Mayberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

4.  Field potential 1/f activity in the subcallosal cingulate region as a candidate signal for monitoring deep brain stimulation for treatment-resistant depression.

Authors:  Ashan Veerakumar; Vineet Tiruvadi; Bryan Howell; Allison C Waters; Andrea L Crowell; Bradley Voytek; Patricio Riva-Posse; Lydia Denison; Justin K Rajendra; Johnathan A Edwards; Kelly R Bijanki; Ki Sueng Choi; Helen S Mayberg
Journal:  J Neurophysiol       Date:  2019-07-17       Impact factor: 2.714

5.  Local field potential recordings in a non-human primate model of Parkinsons disease using the Activa PC + S neurostimulator.

Authors:  Allison T Connolly; Abirami Muralidharan; Claudia Hendrix; Luke Johnson; Rahul Gupta; Scott Stanslaski; Tim Denison; Kenneth B Baker; Jerrold L Vitek; Matthew D Johnson
Journal:  J Neural Eng       Date:  2015-10-15       Impact factor: 5.379

Review 6.  The Human BNST: Functional Role in Anxiety and Addiction.

Authors:  S N Avery; J A Clauss; J U Blackford
Journal:  Neuropsychopharmacology       Date:  2015-06-24       Impact factor: 7.853

7.  Prefrontal Connectivity and Glutamate Transmission: Relevance to Depression Pathophysiology and Ketamine Treatment.

Authors:  Chadi G Abdallah; Christopher L Averill; Ramiro Salas; Lynnette A Averill; Philip R Baldwin; John H Krystal; Sanjay J Mathew; Daniel H Mathalon
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-10

Review 8.  Targeting Neuronal Networks with Combined Drug and Stimulation Paradigms Guided by Neuroimaging to Treat Brain Disorders.

Authors:  Carl L Faingold; Hal Blumenfeld
Journal:  Neuroscientist       Date:  2015-07-06       Impact factor: 7.519

Review 9.  A Shared Vision for Machine Learning in Neuroscience.

Authors:  Mai-Anh T Vu; Tülay Adalı; Demba Ba; György Buzsáki; David Carlson; Katherine Heller; Conor Liston; Cynthia Rudin; Vikaas S Sohal; Alik S Widge; Helen S Mayberg; Guillermo Sapiro; Kafui Dzirasa
Journal:  J Neurosci       Date:  2018-01-26       Impact factor: 6.709

Review 10.  Neuroimaging Biomarkers of New-Onset Psychiatric Disorders Following Traumatic Brain Injury.

Authors:  Andrew R Mayer; Davin K Quinn
Journal:  Biol Psychiatry       Date:  2021-06-12       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.